NWBO
Northwest Biotherapeutics Inc
$0.18
0.01 (3.16%) Today
— up— down
Market Cap
$307M-22.2%
Revenue (TTM)
$1.48M+1.6%
Net Income (TTM)
$-48,807,198
$-48,807,198EPS (TTM)
-0.03
-0.03Shares Out
1.64B
1.64BOpen
$0.19
$0.19Previous Close
$0.19
$0.19Day Range
$0.18 – $0.19
$0.18 – $0.1952-Week Range
$0.18 – $0.37
$0.18 – $0.37Beta
-0.60
-0.60Earnings Date
Aug 12, 2026
Aug 12, 2026Volume
1.35M
1.35MAvg Volume
2.95M
2.95MAnalyst Rating
Buy
BuyExchange
OTC MARKETS
OTC MARKETSAbout NWBO
Northwest Biotherapeutics, Inc. is a development-stage American pharmaceutical company headquartered in Maryland that focuses on developing immunotherapies against different types of cancer. It was founded in 1996 by Alton L. Boynton.
Related
News
The $20,000 new vehicle is all but extinct—what the most affordable new car looks like now
CNBC · 48m ago
Bitcoin's summer swoon creates unique trade in Strategy
CNBC · 1h ago
US factory activity eases off four-year high; input prices remain elevated - Reuters
Reuters · 1h ago
Cramer shares next steps for a software stock after a rare bullish analyst call
CNBC · 1h ago
S&P 500, Dow rise after Warsh says inflation risks have eased - Reuters
Reuters · 1h ago